Will Edwards Lifesciences (EW) Top Q1 Earnings Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 22, 12:00PM CDT
The combination of Edwards' (EW) Zacks Rank #3 and +3.85% ESP makes us confident of a positive earnings beat at the company.
BIIB: 423.57 (+1.46), EW: 140.87 (+0.39), MRTX: 27.86 (-0.19), MEIP: 2.08 (-0.16)
Will Mead Johnson's (MJN) Q1 Earnings Surprise Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 21, 12:50PM CDT
Looking forward, Mead Johnson (MJN) continues to pursue investments in the higher growth channels in China, particularly the eCommerce and super-high premium segments that focus mostly on imported products.
BIIB: 423.57 (+1.46), MJN: 98.92 (-1.00), MRTX: 27.86 (-0.19), MEIP: 2.08 (-0.16)
ResMed (RMD) Poised to Outshine Q3 Earnings Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 21, 12:40PM CDT
Currently, ResMed (RMD) is investing in both respiratory care and sleep apnea channel development to create and lead in both sleep apnea and home ventilation markets in the Asia-Pacific region.
BIIB: 423.57 (+1.46), RMD: 73.28 (+0.17), MRTX: 27.86 (-0.19), MEIP: 2.08 (-0.16)
Can The Uptrend Continue for MEI Pharma (MEIP)?